- Home
- NGS vs PRTA Comparison
NGS vs PRTA Comparison
Compare NGS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | PRTA |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.2M | 495.8M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | NGS | PRTA |
|---|---|---|
| Price | $34.41 | $9.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $35.67 | $18.86 |
| AVG Volume (30 Days) | 106.9K | ★ 742.4K |
| Earning Date | 11-10-2025 | 02-19-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | ★ 14.85 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $166,824,000.00 | $11,786,000.00 |
| Revenue This Year | $9.83 | N/A |
| Revenue Next Year | $14.49 | $819.08 |
| P/E Ratio | $23.65 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $16.73 | $4.32 |
| 52 Week High | $35.01 | $16.67 |
Technical Indicators
Market Signals| Indicator | NGS | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | 60.63 | 41.94 |
| Support Level | $33.24 | $8.89 |
| Resistance Level | $35.01 | $9.69 |
| Average True Range (ATR) | 1.00 | 0.41 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 79.00 | 30.73 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.